PXN and metastatic malignant neoplasm in the lymph nodes: Analyzing the correlation between PXN‐AS1‐L expression levels and clinicopathologic characteristics showed that high expression levels of PXN‐AS1‐L is positively associated with advanced clinical stages and lymph node metastasis (N classification) in these 72 NPC cases (Table 1).